Home > Educational Program > Women's Health CME

Women's Health CME

Internal Medicine 2014 offered a rich program of courses in the area of Women's Health.


Clinical Triad: Breast, Prostate, and Lung Cancer Screening

This course answers the following questions:

Segment A: Breast Cancer Learning Objectives:

1. What is the optimal method and timing for initiation of breast cancer screening, and when should it be stopped?

2. What are the roles of mammography, MRI, and ultrasound in screening?

3. How should an identified breast mass be evaluated?

Segment B: Prostate Cancer Learning Objectives:

1. Who should be screened for prostate cancer?

2. What PSA level is of concern in a given individual?

3. What testing is appropriate for further evaluating an elevated PSA level?

Segment C: Lung Cancer Learning Objectives:

1. Who should get low-dose CT scans?

2. How should lung findings be further evaluated and followed?

3. What is the appropriate follow-up management for incidentally discovered findings in other organs?

Moderator: Peter W. Marks, MD, PhD, FACP; Panelists: Marc B. Garnick, MD, FACP; David E. Midthun, MD, FACP; Kevin Oeffinger, MD


Complete Contraceptive Tool Kit: Cases and Demos, A

Participants in this course will:

  • Review the newest contraceptives and how they compare to the older products.
  • Understand the rationale for choosing between agents.
  • Discuss medical scenarios that would dictate use of one contraceptive over another.
  • Increase comfort with such contraceptives as IUDs, NuvaRing, diaphragm, cervical cap Implanon/Nexplanon, and the Essure device by using models.
  • Address current controversies in the contraceptive literature.

Director: Pelin Batur, MD, NCMP, CCD, FACP; Co-Directors: Sarah Pickle, MD; Kristi Tough DeSapri, MD


Female Sexual Health

This course answers the following questions:

  • What is the epidemiology of female sexual dysfunction?
  • What is the general approach to evaluation of sexual dysfunction in women?
  • What is the relationship of menopause to female sexual dysfunction? Does menopausal hormone therapy improve sexual function? Are other pharmacotherapies (e.g., testosterone) effective?
  • How should women with sexual dysfunction attributed to antidepressant use be treated? What other medications are commonly associated with sexual dysfunction in women?

Professor: Catherine A. Matthews, MD


Menopause 2014

This course answers the following questions:

  • What new information is available about signs and symptoms of the menopause transition?
  • What are effective nonhormonal and hormonal treatments for vasomotor symptoms and vaginal atrophy? What are their risks and benefits?
  • What is the role of complementary and alternative medicine in the treatment of menopausal symptoms?
  • What data are available about the use of "bioidentical" hormones during menopause?

Professor: Janet P. Pregler, MD, FACP


Osteoporosis: Controversies around Starting and Stopping Bisphosphonate Therapy

This course answers the following questions:

  • What are the indications for initiating bisphosphonate therapy, and what are the alternatives?
  • How can glucocorticoid-induced bone loss be minimized?
  • After how many years should a bisphosphonate be stopped? And in whom?
  • How should bone health be monitored when patients are off bisphosphonate treatment?
  • Under what conditions should restarting a bisphosphonate be considered?

Professor: Elizabeth A. Streeten, MD


Screening in Women: Cervical, Breast, and Ovarian Cancer

This course answers the following questions:

  • What are the current guidelines for Pap tests and the use of screening HPV tests? Which women should not receive Pap tests?
  • What is the evidence for and against mammographic screening for women age 40 to 49 years? What is the evidence for mammographic screening for women aged 70 years or older, and what are current guideline recommendations for mammographic screening of older women?
  • Which women should receive screening breast MRI?
  • Which women should be referred for BRCA gene testing?
  • Is there a role for screening pelvic examination, CA-125, or transvaginal ultrasonography in women at high risk for ovarian cancer?

Professor: Jodi L. Friedman, MD, FACP


Oh, Baby: The Pregnant Inpatient

This course answers the following questions:

  • How do the physical examination and laboratory findings differ between a healthy non-pregnant patient and a woman who is pregnant?
  • What are the most common conditions that result in inpatient consultation of the hospitalist service by the obstetrician? For these conditions, when should a team approach with subspecialty involvement be considered?
  • Which medications and imaging modalities for common inpatient conditions are preferred, and which should be avoided?

Professor: Karen Rosene-Montella, MD, FACP


Update in Women's Health CME

This course covers the following topics:

  • Screening strategies for women with dense breasts
  • Interval for repeat screening in women with low bone density
  • Birth outcomes after gastric bypass
  • Risks and benefits of menopause hormone therapy
  • Risks of valproic acid for women who may become pregnant Risks and benefits of adding HPV to screening cytology for cervical cancer Risks and benefits of oral contraceptives in women with BRCA mutations
  • Extending adjuvant tamoxifen for breast cancer to 10 years
  • Risks and benefits of adding HPV to screening cytology for cervical cancer
  • Risks and benefits of oral contraceptives in women with BRCA mutations

Moderator: Janet P. Pregler, MD, FACP; Co-Moderator: Carolyn J. Crandall, MD, MS, FACP


Urinary Incontinence in Women

This course answers the following questions:

  • Should internists screen for urinary incontinence in women?
  • What nonpharmacologic approaches are proven to improve continence in women?
  • Are newer pharmacotherapies better than those available as generics?
  • When should a woman be referred to a specialist? What are the reasons to consult a urogynecologist compared with a urologist?
  • When is a procedure or surgery indicated, and what are the success rates of available options?
  • What type of evaluation should internists do before initiating treatment of urinary incontinence?

Professor: Catherine E. DuBeau, MD


Women and Heart Disease

This course answers the following questions:

  • How do women differ from men with respect to risk for coronary artery disease?
  • Are the risk factors for women different than for men?
  • Are the management outcomes for women different than for men, and why?
  • What are the current guidelines in prevention of heart disease in women?
  • Why do the symptoms of women differ from those of men?

Professor: Annabelle S. Volgman, MD, FACC


Visit www.playbackacp.com to purchase Webcasts and recordings of select sessions from Internal Medicine 2014.